Compound Radar

Warby Parker Inc. (WRBY) Stock Analysis

Price $24.76
Market cap $3.06B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

63
63/100 Good Quality
  • Financial Health 70
  • Profitability 40
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 70

Why this rating?

Health 63/100 — Good Quality

Strongest Business Quality 75/100
Softest Profitability 40/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Warby Parker Inc. (WRBY) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Warby Parker Inc. 63/100 (Good Quality) due to high business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Elevated

Financial highlights

Valuation

  • P/E 412.67
  • Forward P/E 40.27
  • EV/Revenue 3.26

Profitability

  • Revenue Growth 9.8%
  • Gross Margin 53.1%
  • Operating Margin -3.6%
  • Net Margin 0.8%
  • ROE 2.1%

Financial strength

  • Cash $292.67M
  • Debt $250.98M
  • Net Cash $41.69M
  • Free Cash Flow $43.74M
  • Current Ratio 2.27

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Warby Parker Inc. (WRBY).

View Methodology & FAQ →